Aptatargets
Madrid, ES · 1 known investors
aptaTargets is a clinical-stage biopharmaceutical company developing therapeutic aptamers for acute indications where inflammation causes damage, such as ischemic stroke, intracerebral hemorrhage, myocardial infarction, and multiple sclerosis. Its lead candidate ApTOLL is a neuroprotective drug for acute ischemic stroke that blocks TLR4 activation.
BiotechHealthtech